Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorUniversity of Buenos Aires-
Autor(es): dc.creatorQuijia, Christian Rafael-
Autor(es): dc.creatorEnríquez, Andreina Quevedo-
Autor(es): dc.creatorZappia, Carlos Daniel-
Autor(es): dc.creatorPeroni, Roxana Noemí-
Autor(es): dc.creatorChorilli, Marlus-
Data de aceite: dc.date.accessioned2025-08-21T15:31:58Z-
Data de disponibilização: dc.date.available2025-08-21T15:31:58Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2023-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.2174/0929867330666230608145125-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/297718-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/297718-
Descrição: dc.descriptionAccording to Global Cancer Statistics, breast cancer is the second leading cause of mortality in women. While there are several treatments for breast cancer, they are not al-ways effective. In most cases, after initial treatment, patients may present a low response to therapy, more severe relapses, and even drug resistance. Hence, more effective and targeted therapies are needed. Recently, the use of nanoparticles has emerged as a promising alterna-tive that will allow the controlled release of drugs in response to stimuli, precise delivery to the site of action, lower levels of toxicity, and fewer side effects. In this review, we provide an overview of the recent evidence proposing the delivery of inhibitory molecules encapsulated in nanoparticles as a new therapy for breast cancer that targets the signaling pathways governing the processes of tumor formation, maintenance, and expansion.-
Descrição: dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
Descrição: dc.descriptionDepartment of Drugs and Medicines School of Pharmaceutical Sciences of São Paulo State University (UNESP), Rodovia Araraquara Jau, Km 01 – s/n – Campos Ville, Sao Paulo-
Descrição: dc.descriptionNational Council for Scientific and Technical Research (CONICET) Institute of Pharmacological Research (ININFA) University of Buenos Aires, Junín 956 5°-
Descrição: dc.descriptionInstitute of Pharmacological Research (ININFA UBA-CONICET) Faculty of Pharmacy and Biochemistry University of Buenos Aires, Junín 956 5°-
Descrição: dc.descriptionDepartment of Drugs and Medicines School of Pharmaceutical Sciences of São Paulo State University (UNESP), Rodovia Araraquara Jau, Km 01 – s/n – Campos Ville, Sao Paulo-
Descrição: dc.descriptionFAPESP: 2018/21119–0-
Formato: dc.format726-761-
Idioma: dc.languageen-
Relação: dc.relationCurrent Medicinal Chemistry-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectbreast cancer-
Palavras-chave: dc.subjectdelivery-
Palavras-chave: dc.subjectdrugs-
Palavras-chave: dc.subjectinhibitory molecules-
Palavras-chave: dc.subjectNanoparticle-
Palavras-chave: dc.subjectnanosystem-
Título: dc.titleAdministration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.